NCT06917872View on ClinicalTrials.gov

A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 29, 2025

Primary Completion Date

September 9, 2025

Study Completion Date

September 9, 2025

Conditions
Healthy
Interventions
DRUG

BI 1291583

BI 1291583

DRUG

erythromycin

erythromycin

Trial Locations (1)

13627

CRS Clinical Research Services Berlin GmbH, Berlin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06917872 - A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood | Biotech Hunter | Biotech Hunter